Top compounds associated with response to TLDC2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA PD318088 CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.19 7e-06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 9e-06
mRNA YM-155 GDSC1000 pan-cancer AAC -0.16 1e-05
Download CSV